Snowden Capital Advisors LLC Halozyme Therapeutics, Inc. Transaction History

Snowden Capital Advisors LLC

  • $3.29 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Jan 08, 2024
SELL
$13.9 - $21.83 $272,440 - $427,867
-19,600 Closed
0 $0
Q3 2019

Jan 08, 2024
SELL
$15.2 - $17.69 $68,400 - $79,605
-4,500 Reduced 18.67%
19,600 $3.04 Million
Q2 2019

Jan 08, 2024
BUY
$14.75 - $17.26 $355,475 - $415,966
24,100 New
24,100 $3.38 Million

Others Institutions Holding HALO

# of Institutions
542
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $7.35B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email